This might be due to the possibility that FBXO7 is frequently downregulated in HCC patients by the mutation of TP53 or other tumor suppressor genes, leading to high PRMT1 protein abundance to support HCC development. This evidence concerns the gene PRMT1 and hepatocellular carcinoma.